1. Introduction
===============

Octocorals belonging to the *Scleronephthya* genus have been well-recognized as marine organisms containing large quantities of steroids that exhibit varying degrees of bioactivities, such as cytotoxicity and anti-inflammatory activity \[[@B1-ijms-15-10136],[@B2-ijms-15-10136],[@B3-ijms-15-10136],[@B4-ijms-15-10136],[@B5-ijms-15-10136],[@B6-ijms-15-10136],[@B7-ijms-15-10136]\]. In connection with our investigations of bioactive substances from marine organisms, a soft coral *Scleronephthya flexilis* (Thomson & Simpson, 1909, phylum Cnidaria, class Anthozoa, order Alcyonacea, family Nephtheidae) was selected for study ([Scheme 1](#ijms-15-10136-f005){ref-type="scheme"}), as the ethyl acetate extract of this organism was found to exhibit cytotoxicity against the MOLT-4 human acute lymphoblastic leukemia (IC~50~ = 5.1 μg/mL). Our chemical investigation of this organism led to the isolation of a new metabolite, 3β-methoxy-5,20-pregnadiene (**1**), and two known analogues, 3β-acetoxy-5,20-pregnadiene (**2**) \[[@B2-ijms-15-10136],[@B6-ijms-15-10136],[@B8-ijms-15-10136],[@B9-ijms-15-10136]\] and 5α-pregna-1,20-dien-3-one (**3**) \[[@B1-ijms-15-10136],[@B2-ijms-15-10136],[@B4-ijms-15-10136],[@B6-ijms-15-10136],[@B10-ijms-15-10136],[@B11-ijms-15-10136],[@B12-ijms-15-10136],[@B13-ijms-15-10136],[@B14-ijms-15-10136],[@B15-ijms-15-10136],[@B16-ijms-15-10136],[@B17-ijms-15-10136]\] ([Scheme 1](#ijms-15-10136-f005){ref-type="scheme"}). The structures of steroids **1**--**3** were elucidated on the basis of spectroscopic methods and by comparison of data with those of the related metabolites. The absolute configuration of steroid **2** was further confirmed by single-crystal X-ray diffraction analysis. The ability of steroid **3** to inhibit the growth of MOLT-4 cells was evaluated.

![The soft coral *Scleronephthya flexilis* and the structures of 3β-methoxy-5,20-pregnadiene (**1**), 3β-acetoxy-5,20-pregnadiene (**2**), 5α-pregna-1,20-dien-3-one (**3**) and 3β-hydroxy-5,20-pregnadiene (**4**).](ijms-15-10136-g005){#ijms-15-10136-f005}

2. Results and Discussion
=========================

3β-Methoxy-5,20-pregnadiene (**1**) was found to have the molecular formula C~22~H~34~O (6° of unsaturation) by the HRESIMS at *m*/*z* 337.25027 (calcd for C~22~H~34~ONa, 337.25019). The ^13^C and DEPT spectra of **1** showed 22 carbon signals, including three methyls, eight sp^3^ methylenes, an sp^2^ methylene, five sp^3^ methines (including an oxymethine), two sp^2^ methines, two sp^3^ quaternary carbons and an sp^2^ quaternary carbon ([Table 1](#ijms-15-10136-t001){ref-type="table"}). The ^1^H NMR spectra showed the presence of two tertiary methyls (δ~H~ 0.61, 1.01, each 3H, s), a methoxy group (δ~H~ 3.36, 3H, s), an oxymethine (δ~H~ 3.06, 1H, m), a vinyl group (δ~H~ 5.77, 1H, ddd, *J* = 16.8, 10.5, 7.7 Hz; 4.98, 1H, dd, *J* = 16.8, 1.4 Hz; 4.97, 1H, dd, *J* = 10.5, 1.4 Hz) and a trisubstituted olefin group (δ~H~ 5.36, 1H, br s) ([Table 1](#ijms-15-10136-t001){ref-type="table"}). These spectroscopic data showed that **1** might have a pregnane skeleton.
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^1^H (700 MHz, CDCl~3~) and ^13^C (175 MHz, CDCl~3~) NMR data for steroid **1**.

  Position   δ~H~ (*J* in Hz)                           δ~C~, Multiple
  ---------- ------------------------------------------ ----------------
  1          1.88 ddd (12.6, 4.2, 3.5), 1.05 m          37.3, CH~2~
  2          1.92 ddd (12.6, 3.5, 2.8), 1.43 m          28.0, CH~2~
  3          3.06 m                                     80.4, CH
  4          2.39 (12.6, 4.2, 2.1), 2.16 m              38.7, CH~2~
  5                                                     141.0, C
  6          5.36 br s                                  121.5, CH
  7          2.01 m, 1.57 m                             32.0, CH~2~
  8          1.51 m                                     32.0, CH
  9          0.96 m                                     50.5, CH
  10                                                    37.0, C
  11         1.57 m, 1.48 dd (10.5, 5.6)                20.7, CH~2~
  12         1.72 ddd (12.6, 4.2, 2.8), 1.05 m          37.4, CH~2~
  13                                                    43.4, C
  14         1.04 m                                     56.0, CH
  15         1.69 m, 1.21 dd (11.9, 5.6)                24.9, CH~2~
  16         1.79 m, 1.57 m                             27.2, CH~2~
  17         1.96 m                                     55.4, CH
  18         0.61 s                                     12.8, CH~3~
  19         1.01 s                                     19.4, CH~3~
  20         5.77 ddd (16.8, 10.5, 7.7)                 139.8, CH
  21         4.98 dd (16.8, 1.4), 4.97 dd (10.5, 1.4)   114.5, CH~2~
  3-OCH~3~   3.36 s                                     55.6, CH~3~

The molecular skeleton of **1** was established by ^1^H−^1^H correlation spectroscopy (COSY) and heteronuclear multiple-bond coherence (HMBC) correlations as shown in [Figure 1](#ijms-15-10136-f001){ref-type="fig"}, in which C-3 (δ~C~ 80.4) was correlated with protons of a methoxy group (δ~H~ 3.36). Thus, similar to the structure of a known compound, 3β-hydroxy-5,20-pregnadiene (**4**) \[[@B8-ijms-15-10136],[@B9-ijms-15-10136]\] ([Scheme 1](#ijms-15-10136-f005){ref-type="scheme"}), **1** has a methoxy substituent at C-3. The relative stereochemistry of **1** was elucidated by correlations in a nuclear Overhauser effect spectroscopy (NOESY) experiment ([Figure 1](#ijms-15-10136-f001){ref-type="fig"}). The NOESY correlations between H~3~-18/H-20, H~3~-18/H-8, and H-8/H~3~-19 revealed the β-orientations of H-8, H~3~-18, H~3~-19, and the vinyl group at C-17, and α-orientations of H-9, H-14 and H-17. It was found that one of the methylene protons at C-4 (δ~H~ 2.39) exhibited a correlation with H~3~-19, and therefore it was assigned as H-4β, and the other C-4 proton (δ~H~ 2.16) as H-4α. There was a correlation between H-4α and H-3 (δ~H~ 3.06), indicating that the methoxy group at C-3 was β-oriented. Based on above spectral evidence, the structure of **1** was established as 3β-methoxy-5,20-pregnadiene.

![Selective key ^1^H--^1^H correlation spectroscopy (COSY), heteronuclear multiple-bond coherence (HMBC) and nuclear overhauser effect spectroscopy (NOESY) correlations for **1**.](ijms-15-10136-g001){#ijms-15-10136-f001}

Steroid **2** (3β-acetoxy-5,20-pregnadiene) was first obtained by chemical conversion from pregna-5,20-dien-3β-ol (**4**) in 1948 by Julian's group \[[@B8-ijms-15-10136]\] and the natural steroid **2** was isolated from the octocorals *Scleronephthya* sp. \[[@B2-ijms-15-10136]\] and *Scleronephthya gracillimum* \[[@B6-ijms-15-10136]\]. Its structure, including the absolute configuration, was determined by X-ray diffraction analysis for the first time in this study ([Figure 2](#ijms-15-10136-f002){ref-type="fig"}).

![Molecular plot of **2** with confirmed absolute configuration.](ijms-15-10136-g002){#ijms-15-10136-f002}

A well-known marine origin steroid, 5α-pregna-1,20-dien-3-one (**3**), was obtained in this study. Steroid **3** was first isolated from an unidentified soft coral from Canton Island, Pacific Ocean \[[@B10-ijms-15-10136]\], and this compound has been obtained from various octocorals such as *Alcyonium gracillimum* \[[@B11-ijms-15-10136]\], *Capnella erecta* \[[@B12-ijms-15-10136]\], *Capnella thyrsoidea* \[[@B13-ijms-15-10136]\], *Scleronephthya pallida* \[[@B1-ijms-15-10136]\], *Scleronephthya gracillimum* \[[@B4-ijms-15-10136],[@B6-ijms-15-10136]\], *Scleronephthya* sp. \[[@B2-ijms-15-10136]\], *Sinularia papillosa* \[[@B14-ijms-15-10136]\], *Sinularia* sp. \[[@B15-ijms-15-10136]\] and *Spongodes* sp. \[[@B16-ijms-15-10136]\]. The ^1^H and ^13^C data of **3** were identical to those of known pregnanes described previously \[[@B2-ijms-15-10136],[@B10-ijms-15-10136],[@B11-ijms-15-10136],[@B12-ijms-15-10136],[@B13-ijms-15-10136],[@B14-ijms-15-10136],[@B17-ijms-15-10136]\] confirming that **3** was 5α-pregna-1,20-dien-3-one.

The cytotoxicities of steroids **2** and **3** towards human leukemia cells, including MOLT-4 (acute lymphoblastic leukemia), HL-60 (acute promyelocytic leukemia) and K-562 (chronic myelogenous leukemia) cells, were studied, and the results are shown in [Table 2](#ijms-15-10136-t002){ref-type="table"}. MOLT-4 was the cell line most sensitive to the cytotoxic effects of 5α-pregna-1,20-dien-3-one (**3**). This encouraged us to expand our cytotoxicity study with the aim of revealing the mechanism of action of **3** against leukemia cancer cell lines, which we pursued in the current study.
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Cytotoxic data of steroids **2** and **3**.

  Compounds         Cell Lines IC~50~ (g/mL)           
  ----------------- -------------------------- ------- ------
  **2**             NA                         NA      NA
  **3**             2.15                       3.14    8.32
  Doxorubicin ^a^   0.004                      0.001   0.15

^a^ Doxorubicin was used as a positive control and NA = not active at 20 μg/mL for 72 h.

We determined the effects of **3** treatment on the cell growth of different leukemia cell lines. Initially, we determined the IC~50~ values of **3** against MOLT-4, HL-60 and K-562 cells after 72 h and found that the cell growth of MOLT-4, HL-60 and K-562 cells were inhibited in dose-dependent manner with the IC~50~ values of 2.15, 3.14 and 8.32 μg/mL, respectively ([Figure 3](#ijms-15-10136-f003){ref-type="fig"}A and [Table 2](#ijms-15-10136-t002){ref-type="table"}). HL-60 and K-562 cell lines are p53-negative cell lines \[[@B18-ijms-15-10136]\]. MOLT-4 cells, originally derived from the same patient as MOLT-3 cells, are lymphoblastoid T cells and express normal p53 \[[@B19-ijms-15-10136]\]. In addition, the cell growth of different leukemia cells was significantly suppressed by **3** treatment in a dose-dependent manner, regardless of p53 status ([Figure 3](#ijms-15-10136-f003){ref-type="fig"}A). We then evaluated whether the cytotoxicity of **3** is associated with apoptosis by examining the effect of **3** on cells stained with annexin V-FITC and propidium iodide (PI). As shown in [Figure 3](#ijms-15-10136-f003){ref-type="fig"}B, treatment with **3** at concentrations of 0, 1.25, 2.5 and 5 μg/mL for 24 h increased the percentages of annexin-positive cells from 4.1% to 23.3%, 61.1% and 98.2% as compared with the control group in MOLT-4 cells, respectively. To determine whether the cytotoxic effect of **3** is specific for cancer cells, we examined the effect of **3** on the viability of normal rat peripheral blood mononuclear cells (PBMC). At the highest dose (10 μg/mL), **3** treatment caused 71.6% suppression in the viability of PBMCs, nevertheless, doxorubicin treatment induced 99.9% suppression for 24 h ([Figure 3](#ijms-15-10136-f003){ref-type="fig"}C). Compared with PBMCs, **3** suppressed 99.9% of cell growth in MOLT-4 cells for 24 h. Thus, it is concluded that cytotoxic effect of **3** is more sensitive towards MOLT-4 cells compared to the normal rat PBMCs. In addition, our result suggested that growth inhibition of **3** is mediated with induction of apoptosis and operated independently in P53 pathway.

This encouraged us to expand our cytotoxicity study with the aim of revealing the mechanism of action of **3**-induced leukemia MOLT-4 cells apoptosis. Mitochondria are organelles which play an important role in the life and death of the cells. Their importance is mainly attributed to energy production in the form of ATP. Additionally, mitochondrial dysfunction participates in the induction of apoptosis \[[@B20-ijms-15-10136]\]. To examine whether the antiproliferative and apoptotic effects of **3** are involved mitochondrial dysfunction in MOLT-4 cells, flow cytometric assays with various fluorescent dyes were utilized. Different concentrations of **3** (0, 1.25, 2.5 and 5 μg/mL) were used for 24 h, and the change in the mitochondrial membrane potential (MMP) was analyzed. Treatment with **3** (1.25, 2.5 or 5 μg/mL) led to 23.8%, 49.2% and 93.8% disruption of the MMP, respectively, as detected using JC-1 cation dye in MOLT-4 cells ([Figure 4](#ijms-15-10136-f004){ref-type="fig"}). The recent result evidenced that one of **3** targets as an apoptosis inducer is to disrupt the bioenergetic steps of the mitochondria-medicated pathway.

![Cytotoxic and apoptotic effects of 5α-pregna-1,20-dien-3-one (**3**) on leukemia cells. (**A**) Leukemia cells were treated with varying concentrations of **3** for 72 h. Cell growth was assayed by MTT methods; (**B**) MOLT-4 cells were treated with varying concentrations of **3** for 24 h, then labeled with annexin V-FITC and PI (propidium iodide) and analyzed using flow cytometry; and (**C**) The viability of normal rat PBMCs were determined with different doses of **3** and doxorubicin. Results are presented as mean ± SD of three independent experiments.](ijms-15-10136-g003){#ijms-15-10136-f003}

![Flow cytometric results showing the effects of different concentrations of **3** (1.25, 2.5 and 5 μg/mL) on the disruption of the mitochondrial membrane potential (MMP).](ijms-15-10136-g004){#ijms-15-10136-f004}

3. Experimental Section
=======================

3.1. General Experimental Procedures
------------------------------------

Optical rotations were measured using a Jasco P-1010 digital polarimeter (Japan Spectroscopic Corporation, Tokyo, Japan). Infrared spectra were recorded on a Varian Diglab FTS 1000 FT-IR spectrometer (Varian Inc., Palo Alto, CA, USA); peaks are reported in cm^−1^. NMR spectra were recorded on a Bruker AVIII HD 700X NMR spectrometer (Bruker, Bremen, Germany) or on a Varian Mercury Plus 400 NMR spectrometer (Varian Inc., Palo Alto, CA, USA) using the residual CHCl~3~ signal (δ~H~ 7.26 ppm) as the internal standard for ^1^H NMR and CDCl~3~ (δ~C~ 77.1 ppm) for ^13^C NMR. Coupling constants (*J*) are given in Hz. ESIMS and HRESIMS were recorded using a Bruker 7 Tesla solariX FTMS system (Bruker, Bremen, Germany). Column chromatography was performed on silica gel (230--400 mesh, Merck, Darmstadt, Germany). TLC was carried out on precoated Kieselgel 60 F~254~ (0.25 mm, Merck, Darmstadt, Germany); spots were visualized by spraying with 10% H~2~SO~4~ solution followed by heating. Normal-phase HPLC (NP-HPLC) was performed using a system comprised of a Hitachi L-7110 pump (Hitachi Ltd., Tokyo, Japan) and a Rheodyne 7725 injection port (Rheodyne LLC, Rohnert Park, CA, USA). Two normal-phase columns (Supelco Ascentis^®^ Si Cat \#:581515-U, 250 mm × 21.2 mm, 5 µm; 581514-U, 250 mm × 10 mm, 5 µm, Sigma-Aldrich. Com., St. Louis, MO, USA) were used for NP-HPLC. Reverse-phase HPLC (RP-HPLC) was performed using a system comprised of a Hitachi L-7100 pump (Hitachi Ltd., Tokyo, Japan), a Hitachi L-2455 photodiode array detector (Hitachi Ltd., Tokyo, Japan), a Rheodyne 7725 injection port (Rheodyne LLC, Rohnert Park, CA, USA) and a reverse column (Varian Polaris C18-A, 250 mm × 10 mm, 5 µm; Varian Inc., Palo Alto, CA, USA).

3.2. Animal Material
--------------------

Specimens of the octocoral *Scleronephthya flexilis* were collected by hand using scuba equipment off the coast of Southern Taiwan in September 2012, and stored in a freezer (−20 °C) until extraction. A voucher specimen (NMMBA-TWSC-12009) was deposited in the National Museum of Marine Biology and Aquarium, Pingtung, Taiwan.

3.3. Extraction and Isolation
-----------------------------

Specimens of the soft coral *Scleronephthya flexilis* (wet weight 1.5 kg, dry weight 562 g) were minced and extracted with ethyl acetate (EtOAc). The EtOAc extract remaining after removal of the solvent (6.7 g) was separated by silica gel and eluted using *n*-hexane/EtOAc in a stepwise fashion from 100:1--pure EtOAc to yield 10 fractions A--J. Fraction C (514 mg) was chromatographed on silica gel using a mixture of *n*-hexane and EtOAc in a stepwise fashion from 45:1 to 10:1 to obtain 10 subfractions C1--C10. Fraction C3 (100 mg) was purified by NP-HPLC using a mixture of *n*-hexane and acetone (100:1) to obtain 8 subfractions C3A--C3H. Fraction C3F (3.1 mg) was repurified by NP-HPLC using a mixture of *n*-hexane and dichloromethane (5:2, flow rate: 1.0 mL/min) to yield 3β-methoxy-5,20-pregnadiene (**1**) (0.6 mg, *t*~R~ = 45 min). Fraction C4 (48 mg) was purified by NP-HPLC using a mixture of *n*-hexane and EtOAc (18:1) to obtain 10 subfractions C4A--C4J. Fraction C4F (38 mg) was repurified by RP-HPLC using a mixture of methanol and H~2~O (98:2, flow rate: 2.0 mL/min) to yield 3β-acetoxy-5,20-pregnadiene (**2**) (17.1 mg, *t*~R~ = 40 min). Fractions D and E were combined (2.76 g) and separated by Sephadex LH-20 using a mixture of dichloromethane and methanol (1:1) to obtain 13 subfractions D1--D13. Fractions D10 and D11 were combined and separated by NP-HPLC using a mixture of *n*-hexane and acetone (10:1) to obtain 8 subfractions D10A--D10H. Fraction D10B was further separated by NP-HPLC, using a mixture of *n*-hexane and dichloromethane (1:1, flow rate: 1.0 mL/min) to yield 5α-pregna-1,20-dien-3-one (**3**) (92.7 mg, *t*~R~ = 26 min).

3β-Methoxy-5,20-pregnadiene (**1**): ![](ijms-15-10136-i001.jpg) −6 (*c* 0.2, CHCl~3~); IR (neat) ν~max~ 1638 cm^−1^; ^1^H (700 MHz, CDCl~3~) and ^13^C (175 MHz, CDCl~3~) NMR data, see [Table 1](#ijms-15-10136-t001){ref-type="table"}; ESIMS: *m*/*z* 337 \[M + Na\]^+^; HRESIMS: *m*/*z* 337.25027 (calcd for C~22~H~34~ONa, 337.25019).

3β-Acetoxy-5,20-pregnadiene (**2**): colorless prisms; mp 143−145 °C; ![](ijms-15-10136-i002.jpg) −60 (*c* 0.2, CHCl~3~); IR (neat) ν~max~ 1727 cm^−1^; ^1^H NMR (400 MHz, CDCl~3~) δ~H~ 5.76 (1H, ddd, *J* = 16.4, 11.2, 7.6 Hz, H-20), 5.38 (1H, br d, *J* = 5.6 Hz, H-6), 4.98 (1H, dd, *J* = 11.2, 0.8 Hz, H-21), 4.97 (1H, dd, *J* = 16.4, 0.8 Hz, H-21\'), 4.60 (1H, m, H-3), 2.32 (2H, m, H~2~-4), 2.03 (3H, s, acetate methyl), 2.01 (1H, m , H-7), 1.98 (1H, m, H-17), 1.88 (1H, m, H-1), 1.86 (1H, m, H-2), 1.79 (1H, m, H-16), 1.73 (1H, m, H-12), 1.70 (1H, m, H-15), 1.60 (1H, m, H-2\'), 1.58 (1H, m, H-7\'), 1.57 (1H, m, H-16\'), 1.54 (1H, m, H-11), 1.46 (1H, m, H-8), 1.42 (1H, m, H-11\'), 1.19 (1H, m, H-15\'), 1.16 (1H, m, H-1), 1.09 (1H, dd, *J* = 13.2, 4.0 Hz, H-12\'), 1.03 (3H, s, H~3~-19), 1.01 (1H, m, H-14), 0.98 (1H, m, H-9), 0.61 (3H, s, H~3~-18); ^13^C NMR (100 MHz, CDCl~3~) δ~C~ 170.5 (C, acetate carbonyl), 139.8 (CH-20), 139.7 (C-5), 122.5 (CH-6), 114.5 (CH~2~-21), 73.9 (CH-3), 55.8 (CH-14), 55.3 (CH-17), 50.3 (CH-9), 43.4 (C-13), 38.1 (CH~2~-4), 37.3 (CH~2~-12), 37.0 (CH~2~-1), 36.7 (C-10), 32.0 (CH-8), 32.0 (CH~2~-7), 27.8 (CH~2~-2), 27.2 (CH~2~-16), 24.9 (CH~2~-15), 21.4 (CH~3~, acetate methyl), 20.6 (CH~2~-11), 19.3 (CH~3~-19), 12.7 (CH~3~-18); ESIMS: *m*/*z* 365 \[M + Na\]^+^; HRESIMS: *m*/*z* 365.2452 (calcd for C~23~H~34~O~2~Na, 365.2451).

5α-Pregna-1,20-dien-3-one (**3**): white powder; mp 116−118 °C; ![](ijms-15-10136-i003.jpg) +45 (*c* 2.3, CHCl~3~); IR (neat) ν~max~ 1682 cm^−1^; ESIMS: *m*/*z* 321 \[M + Na\]^+^. The ^1^H and ^13^C NMR data of **3** were in full agreement with those of reported previously \[[@B2-ijms-15-10136],[@B10-ijms-15-10136],[@B11-ijms-15-10136],[@B12-ijms-15-10136],[@B13-ijms-15-10136],[@B14-ijms-15-10136],[@B17-ijms-15-10136]\].

3.4. X-ray Crystallographic Analysis of Compound 2
--------------------------------------------------

Suitable colorless prisms of **2** were obtained from a solution of acetone. Crystal data and experimental details: C~23~H~34~O~2~, *M*~r~ = 342.50, crystal size 0.21 mm × 0.18 mm × 0.17 mm, crystal system orthorhombic, space group *P*2~1~2~1~2~1~ (\#19), with *a* = 7.3639(4) Å, *b* = 11.5782(6) Å, *c* = 22.7667(11) Å, *V* = 1941.10(17) Å^3^, *Z* = 4, *D*~calcd~ = 1.172 g/cm^3^ and λ (Cu, k~α~) = 1.54178 Å. Intensity data were measured on a Bruker APEX-II CCD diffractometer equipped with a micro-focus Cu radiation source and Montel mirror up to θ~max~ of 66.7° at 100 K. All 12,991 reflections were collected. The structure was resolved by direct methods and refined by a full-matrix least-squares procedure. The refined structure model converged to a final *R*1 = 0.0279, *wR*2 = 0.0717 for 3358 observed reflections (*I* \> 2σ(*I*)) and 229 variable parameters. The absolute configuration was determined by Flack's method, with Flack's parameter determined to be 0.09(6) \[[@B21-ijms-15-10136],[@B22-ijms-15-10136]\].

3.5. Bioassay Material
----------------------

RPMI-1640 medium, fetal calf serum (FCS), tryptan blue, penicillin G and streptomycin were obtained from Gibco BRL (Gaithersburg, MD, USA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), dimethyl sulfoxide (DMSO) and all other chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA).

3.6. MTT Antiproliferative Assay
--------------------------------

MOLT-4 (human acute lymphoblastic leukemia), HL-60 (human acute promyelocytic leukemia) and K-562 (human chronic myelogenous leukemia) cells were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). Rat PBMCs were generated as described previously \[[@B23-ijms-15-10136]\]. Cells were maintained in RPMI-1640 medium supplemented with 10% FCS, 2 mM glutamine, and antibiotics (100 units/mL penicillin and 100 μg/mL streptomycin) at 37 °C in a humidified atmosphere of 5% CO~2~. Cells were seeded at 4 × 10^4^ per well in 96-well culture plates before treatment with different concentrations of the tested compounds. The compounds were dissolved in DMSO (less than 0.02%) and made immediately to 1.25, 2.5, 5, 10 and 20 μg/μL prior to the experiments. After treatment for 72 h, the cytotoxicities of the tested compounds were determined using a MTT cell proliferation assay (thiazolyl blue tetrazolium bromide, Sigma-M2128). The MTT is reduced by the mitochondrial dehydrogenases of viable cells to a purple formazan product. The MTT-formazan product was dissolved in DMSO. Light absorbance values (OD = OD~570~ − OD~620~) were recorded at wavelengths of 570 and 620 nm using an ELISA reader (Anthos labtec Instrument, Salzburg, Austria) to calculate the concentration that caused 50% inhibition (IC~50~), *i.e.*, the cell concentration at which the light absorbance value of the experimental group was half that of the control group. These results were expressed as a percentage of the control ± SD established from *n* = 4 wells per one experiment from three separate experiments.

3.7. Annexin V/PI Apoptosis Assay
---------------------------------

The externalization of phosphatidylserine (PS) and the membrane integrity were quantified using an annexin V-FITC staining kit (Strong Biotech Corporation, Taipei, Taiwan). In brief, 10^6^ cells were grown in 35-mm-diameter plates and were labeled with annexin V-FITC (10 μg/mL) and PI (20 μg/mL) prior to harvesting. After labeling, all plates were washed with a binding buffer and harvested. Cells were resuspended in the binding buffer at a concentration of 2 × 10^5^ cells/mL before analysis by a flow cytometer FACS-Calibur (Becton-Dickinson, San Jose, CA, USA) and CellQuest software. Approximately 10,000 cells were counted for each determination.

3.8. Determination of Mitochondrial Membrane Potential Disruption
-----------------------------------------------------------------

These assays were performed as described previously. MMP disruption was detected with JC-1 cationic dye (5 μg/mL) \[[@B24-ijms-15-10136]\]. In brief, the treated cells were labeled with a specific fluorescent dye for 30 min. After labeling, cells were washed with PBS and resuspended in PBS at a concentration of 1 × 10^6^ cells/mL before analysis by flow cytometry.

3.9. Statistics
---------------

The results were expressed as mean ± standard deviation (SD). Comparison in each experiment was performed using an unpaired Student's *t*-test, and *p* values lower than 0.05 were considered to be statistically significant. (\* *p* \< 0.05; \*\* *p* \< 0.01).

4. Conclusions
==============

In the first study on the chemical constituents of soft coral *Scleronephthya flexilis*, three pregnane-type steroids, including a new metabolite, 3β-methoxy-5,20-pregnadiene (**1**), along with two known compounds, 3β-acetoxy-5,20-pregnadiene (**2**) and 5α-pregna-1,20-dien-3-one (**3**), were isolated. The structure of new steroid **1** was elucidated on the basis of spectroscopic methods. The absolute configuration of steroid **2** was further confirmed by X-ray diffraction analysis for the first time. Our results also suggest that the use of steroid **3** induced MMP disruption, as well as apoptosis in Molt-4 cells. The current work clearly supports the potential application of **3** for leukemia therapy. The soft coral *Scleronephthya flexilis* has been transplanted to culturing tanks located in the National Museum of Marine Biology and Aquarium, Taiwan, for extraction of additional natural products to establish a stable supply of bioactive material.
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